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ABSTRACT
The Consensus Coding Sequence (CCDS) project
provides a dataset of protein-coding regions that
are identically annotated on the human and mouse
reference genome assembly in genome annota-
tions produced independently by NCBI and the En-
sembl group at EMBL-EBI. This dataset is the prod-
uct of an international collaboration that includes
NCBI, Ensembl, HUGO Gene Nomenclature Com-
mittee, Mouse Genome Informatics and University
of California, Santa Cruz. Identically annotated cod-
ing regions, which are generated using an auto-
mated pipeline and pass multiple quality assurance
checks, are assigned a stable and tracked identi-
fier (CCDS ID). Additionally, coordinated manual re-
view by expert curators from the CCDS collabo-
ration helps in maintaining the integrity and high
quality of the dataset. The CCDS data are available
through an interactive web page (https://www.ncbi.
nlm.nih.gov/CCDS/CcdsBrowse.cgi) and an FTP site
(ftp://ftp.ncbi.nlm.nih.gov/pub/CCDS/). In this paper,
we outline the ongoing work, growth and stability of
the CCDS dataset and provide updates on new col-
laboration members and new features added to the
CCDS user interface. We also present expert cura-
tion scenarios, with specific examples highlighting
the importance of an accurate reference genome as-
sembly and the crucial role played by input from the
research community.
INTRODUCTION
Accurate and comprehensive whole genome annotation of
the human andmouse reference genomes is essential to sup-
port many areas of scientific inquiry, including medical re-
search. RefSeq (1) annotation from NCBI (National Cen-
ter for Biotechnology Information) and Ensembl (2) an-
notation from EMBL-EBI (The European Molecular Biol-
ogy Laboratory’s European Bioinformatics Institute) pro-
vided for these species are the primary reference resources
through which biological data are interpreted and reported
by the scientific community. The analytical workflows used
by these separate projects are conceptually similar in that
they both produce gene annotations based on a combi-
nation of computational pipelines and manual curation,
largely based on the interpretation of transcriptomics and
other experimental data. Ultimately, however, Ensembl and
NCBI have developed different rules and guidelines for au-
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tomated and manual annotation or curation, and this has
led to differences between the sets of genes, transcripts and
proteins currently found in these datasets. Such inconsisten-
cies can present a challenge to the scientific community in
their efforts to interpret biological data; for example, when
a disease-associated variant is found to occur in a protein-
coding transcript in one dataset, but a non-coding model in
another. Furthermore, the regular emergence of new data
types and methodologies with which to identify novel tran-
scripts and to gain insights into their functionality mean
that these datasets have the potential to include additional
divergence with each new release.
The Consensus Coding Sequence (CCDS) collaboration
was formed in 2005 to address the issue of discrepancies
between Ensembl and NCBI genome annotations by pro-
ducing a consensus dataset of protein-coding regions with
identical coding sequence (CDS) coordinates on the human
andmouse reference genomes in both annotations. Consen-
sus protein-coding regions, identified by stable and tracked
identifiers (CCDS IDs), and related metadata, are accessi-
ble through a public search page (www.ncbi.nlm.nih.gov/
CCDS). In addition, data are available for bulk download
from an FTP site (ftp://ftp.ncbi.nlm.nih.gov/pub/CCDS/).
A detailed description of methods to access CCDS data, the
CCDS workflow, curation processes and quality assurance
(QA) tests involved in creating the dataset, were published
previously (3–5).
The core of the collaboration relies on consensus build-
ing across members, including NCBI who provide the Ref-
Seq annotation, the Ensembl Genebuild and Ensembl HA-
VANA (Human and Vertebrate Analysis and Annotation)
groups at EMBL-EBI who produce the GENCODE (6)
gene set, University of California Santa Cruz (UCSC), and
the two nomenclature authorities, HUGO Gene Nomen-
clature Committee (HGNC) (7) and Mouse Genome In-
formatics (MGI) (8) who provide standardized human and
mouse gene symbols and names, respectively. To maintain
high-quality annotation, expert curators from the collabo-
rating groups continuously review and discuss CCDS IDs
flagged for review by QA tests, collaboration members and
users. Curators also review regions where there are differ-
ences in protein annotation between the NCBI and En-
sembl genome annotations, to try to reach consensus us-
ing all available data types through a voting process, which
is described in an earlier publication (4). The combination
of CDS annotation concordance across two groups with
different annotation methods and policies, and the regu-
lar review of the resource by expert curators make CCDS
data, a stable and high-confidence option for users focused
on protein-coding genes that are annotated consistently in
the twomajor annotation databases. Therefore, CCDS data
have been used in genome analyses, such as comparison of
whole-genome sequencing andwhole-exome sequencing for
effective detection of disease-causing mutations (9), large-
scale evaluation of proteomics data to determine if genes
have a dominant protein isoform (10) and high-throughput
exome coverage analysis of clinically relevant cardiac genes
(11). In addition, CCDS data are used to design commercial
exome microarrays (12).
In this manuscript, we present the current status of the
CCDS collaboration, describe the updates that have been
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Figure 1. Number of CCDS IDs and genes represented in the human (A)
and mouse (B) CCDS releases. The X-axis indicates the year in which a
CCDS dataset was made public. Details about CCDS releases are available
on the CCDS Releases and Statistics web page (https://www.ncbi.nlm.nih.
gov/CCDS/CcdsBrowse.cgi?REQUEST=SHOW STATISTICS).
made to the CCDS resource since our last report, and we
highlight some of the challenges and future plans of this
ongoing and active collaboration.
GROWTH OF THE CCDS DATASET
The CCDS collaboration releases an update of the human
and mouse CCDS datasets approximately once each year,
following annotation updates of the reference genomes by
either NCBI or Ensembl, or both annotation groups. Since
the first human and mouse data releases in 2005 and 2006,
respectively, the CCDS dataset has seen a steady growth in
the number of new coding regions (CCDS IDs) as well as
the number of genes that have at least one CCDS ID in both
the human (Figure 1A) and mouse (Figure 1B) datasets.
This growth reflects increasing concordance in NCBI and
Ensembl protein-coding region annotations over the years.
The most recent CCDS releases in human (Release 20) and
mouse (Release 21) contain 32 524 and 25 757 CCDS IDs
represented by 18 892 and 20 354 genes, respectively, and
cover∼33.2Mb (1.03%) of the human and 33.7Mb (1.24%)
of the mouse reference genomes. Notably, the growth in re-
cent years is largely due to the addition of new CCDS IDs
representing alternatively spliced transcripts within exist-
ing protein-coding genes, and this trend has continued un-
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Figure 2. Fraction of all genes in a CCDS release that are represented by
at least two current CCDS IDs.
abated up to the current human and mouse releases. This is
evident from Figure 2, which shows a growing trend in the
fraction of total genes in the CCDS dataset that are repre-
sented by at least two protein isoforms in both the mouse
and the human CCDS sets. The increase in detectable splic-
ing variation can be attributed to the identical annotation
of alternatively spliced transcript variants resulting from the
incorporation of new data types into automated pipelines,
as well as curation workflows of the two annotation groups.
It also likely reflects an end to the locus-by-locus ‘growth
phase’ of human annotation as both annotation groups
have manually annotatedmost human genes in their respec-
tive annotation catalogs, and are expected to reach the same
goal in mouse annotation in the next few years. Nonethe-
less, the protein-coding gene count remains dynamic in
both annotation catalogs; we anticipate that both Ensembl
and NCBI will continue to add and remove protein-coding
genes in future releases.
Notably, despite a greater number of protein-coding
genes in the mouse than in the human dataset (as seen in
Figure 1), the Figure 2 graph shows lower numbers for mul-
tiple isoform representation in the mouse data. This is likely
due to the prioritization of curating the human annotation
by both annotation groups. In recent years, however, mouse
curation has received increasing focus at both Ensembl and
NCBI, and this is expected to narrow the gap in the number
of CCDS IDs between the human andmouse datasets in fu-
ture CCDS releases. New human andmouse CCDS releases
are planned before the end of 2017.
The general slow-down in growth over recent releases
(Figures 1 and 2) also suggests increasing stability in the
dataset. To evaluate dataset stability, we assessed the rates
of change for CCDS IDs between releases, including addi-
tions of new CCDS IDs, updates to existing CCDS IDs (in-
dicated by an increment in the CCDS ID version) and with-
drawals of CCDS IDs. Our analyses (Figure 3) show that
larger numbers of CCDS updates andwithdrawals occurred
between earlier CCDS releases than recent CCDS releases.
These results indicate that the CCDS dataset is becoming
increasingly stable, not only at the level of new additions,
but also at the level of individual CCDS ID alteration.
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Figure 3. Changes in the human (A) and mouse (B) datasets with every
new CCDS release. ‘New’ = new CCDS IDs added; ‘dropped’ = CCDS
ID present in the previous release but withdrawn in the subsequent release;
‘updated’ = CCDS IDs that have an incremented accession version com-
pared to the previous release, indicating a sequence update in the coding
region.
CCDS DATABASE UPDATES
Collaborators
In May 2014, the official human and mouse nomenclature
groups, HGNC and MGI, respectively, replaced UCSC as
voting members of the collaboration. UCSC is no longer
an active participant in CCDS curation, although they still
provide QA input on pseudogenes, orthology and conser-
vation during automated CCDS analysis. Representatives
from HGNC and MGI are involved in CCDS policy deci-
sions and in review of specific annotation cases. As voting
members in the CCDS annotation review process, they pro-
vide input on all cases of conflict between NCBI and En-
sembl annotations, highlight individual genes for consider-
ation and raise policy issues for discussion. Their involve-
ment also facilitates timely nomenclature updates prompted
by CCDS curation.
Guidelines
Coordinated curation of human and mouse coding re-
gion annotation by experts in the CCDS collaboration
is crucial for maintaining the high quality of the CCDS
dataset. As different collaborating groups may follow di-
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verse rules for curation, a common set of guidelines was
established for consistent and efficient curation within the
CCDS collaboration. These guidelines are available on the
CCDS web page (https://www.ncbi.nlm.nih.gov/projects/
CCDS/docs/CCDS curation guidelines.pdf) and are de-
scribed in detail in a previous report (4). Curation guide-
lines need to be updated in response to discussions among
collaborators, feedback from research groups and emerg-
ing data types. Several updates to CCDS guidelines have
been made since our last publication (5) and they reflect
changes in CCDS curation policies, which are described in
previous reports (4,5). The updates include rules pertaining
to the selection of translation start codons and guidelines
for the representation of nonsense-mediated mRNA decay
(NMD), inferred exon combination and readthrough gene
representations. Section 2A, which contains guidelines for
start codon selection, was updated to add rules to allow the
use of an in-frame downstream start codon instead of the
first start codon in the open reading frame (ORF). Specific
case examples were included to illustrate scenarios and the
support needed to choose the downstream start codon.
The existence of upstream ORFs (uORFs) in protein-
coding transcripts were previously considered to be evi-
dence for the removal of the protein-coding capacity of a
transcript. In literature-led discussions within the collabo-
ration, it was decided that uORFs are predominantly regu-
latory rather than deterministic, so they are no longer con-
sidered in annotating the CDS.
A new section (Section 2B) was added to the guidelines to
describe rules pertaining to CDS annotation in cases where
the location of the translation start codon suggests that the
transcript may be subject to NMD. Another section (Sec-
tion 2D) was added to describe the CDS annotation for
transcripts that lack full-length support, i.e. a transcript
archived in an International Nucleotide SequenceDatabase
Collaboration (INSDC) (13) database and includes at least
the entire coding region. In some of these cases, a full-length
protein can be inferred from homology, orthology or pub-
lications. In other cases, the coding region is inferred when
the gene contains cassette exons that are supported individ-
ually by transcript, conservation or published data, but full-
length support is lacking. A good example of this is TTN
(CCDS59435.1) which has 363 exons.
A readthrough transcript is annotated when neighbor-
ing genes share transcripts that overlap at least one exon
per gene. Historically a ‘3-gene model’ was used where the
readthrough transcript is considered a part of a separate
gene. A CCDS was generated when there was NCBI and
Ensembl consensus annotation of a coding readthrough
transcript. In some cases, where the overlapping region in-
cluded only the untranslated region (UTR) of the upstream
gene, the readthrough transcript could share the CDS (and
hence, the CCDS ID) with the downstream genes, which
caused confusion. As transcriptional data are increasing
at an exponential rate, we are finding that the existence
of readthrough transcripts is very widespread and most
readthrough transcripts are likely to be non-functional.
Hence, they will now only be considered for inclusion in the
CCDS dataset when there is strong experimental evidence
for their existence and the CDS is unique.
User interface
A CCDS report page includes links to genome browsers in
the ‘Chromosomal Locations’ section (purple icons) that
display the genomic span of the coding sequence (‘Genome
Browser links’) or genomic span of individual coding ex-
ons (browser links in the exon table). In 2014, an additional
link (purple ‘S’ icon) was included in the last column of
the report table at the top of the CCDS report page. This
link opens an interactive combined graphical display (Fig-
ure 4) of the NCBI and Ensembl annotations associated
with the CCDS ID, using the NCBI Sequence Viewer tool.
The graphical display offers several options to customize
the browser view, including the ‘Tracks’ button, which al-
lows a user to load additional data tracks to the default
view.
The curated SwissProt subset of the UniProtKB (14)
database provides additional data relevant to a protein, in-
cluding function, protein features, subcellular location, ex-
pression and structure. To provide access to this data to
CCDS users, since January 2014, CCDS reports include
a section that displays the UniProtKB/SwissProt acces-
sion, including the specific isoform, that matches the CCDS
(example CCDS4565.1). The hyperlinked accession num-
ber in the ‘RelatedUniProtKB/SwissProt’ column provides
the user a direct link to the UniProtKB/SwissProt record.
TheseCCDS:SwissProt accessionmatches are also available
in the CCDS2UniProtKB.[release date/current].txt files in
the CCDS FTP site.
Review status
While the CCDS dataset results from concordant annota-
tion in two independent annotation sets, it also reflectsman-
ual review by curators from the Ensembl and NCBI anno-
tation groups and by curators in the CCDS collaboration.
The greatest value of manual annotation is in the insights
it can provide into the functionality of a given transcript,
i.e. our understanding of what that transcript does (for ex-
ample, encodes a protein) and the ability to critically assess
the validity of all primary data. In 2017, a ‘Review Status’
section was added to the CCDS report page above the ‘Se-
quence IDs’ table to convey to users if a CCDS ID has been
reviewed. Table 1 summarizes the different categories of re-
view status with a brief description of each category. The re-
view status depends onmanual review carried out at two lev-
els. The first level of review is performed by curators in the
individual annotation groups who review genes, transcripts
and proteins as a part of their manual annotation process,
and this review is independent of theCCDSworkflow. Tran-
scripts and proteins are then flagged within each annotation
set to indicate their review status. NCBI-RefSeq accessions
are flagged as ‘validated’ or ‘reviewed’. In the Ensembl an-
notation set, a transcript that is manually annotated has
a VEGA (Vertebrate Genome Annotation) (15) accession
(with ‘OTT’ prefix) in addition to an Ensembl (‘ENS’ pre-
fix) accession, which is indicated in the Transcript window
of the Ensembl genome browser. When the two annotations
are compared to generate the CCDS set, transcripts and
proteins that have gone through this level of review, and
are annotated identically in the Ensembl and NCBI sets, re-
sult in CCDS IDs with a ‘Reviewed (by RefSeq and HA-
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Figure 4. A view of the graphical display accessed from the report page of CCDS3542.1 (https://www.ncbi.nlm.nih.gov/CCDS/CcdsBrowse.cgi?
REQUEST=ALLFIELDS&DATA=CCDS3542&ORGANISM=0&BUILDS=CURRENTBUILDS) using the purple ‘S’ icon. (A) Transcripts and pro-
teins from NCBI Annotation Release 108. (B) Transcripts and proteins from Ensembl Release 85. The green bar indicates the gene; transcripts are shown
in purple and proteins are shown in red color. Positioning the cursor over any of these objects (gene, transcript or protein) opens a tool tip which includes
additional information and links. Proteins in the NCBI annotation display that are in the CCDS set include a link to the CCDS ID in the tool tip. The gray
box to the right (indicated by vertical arrow) is the tool tip corresponding to the protein accession NP 002514.1. Differences between any two objects can
also be revealed as vertical lines (indicated by horizontal arrows) when the objects (NM 002523.2 and ENST00000265634 in the figure) are selected using
the ‘Control’ or ‘Command’ button on the keyboard.
VANA)’ status (example CCDS83093.1). It is noteworthy
that the VEGA genome browser was retired and archived
early in 2017 but manually annotated transcripts continue
to be accessible in the Ensembl genome browser. In Ensembl
release files, manually annotated transcripts are indicated as
ensembl havana or havana.
A second level of manual review includes the review
of CCDS IDs flagged by QA tests for errors or incon-
sistencies. In addition, specific review cases are raised
by individual collaborators or external databases (e.g.
UniProt/SwissProt). CCDS users can also request the
review of CCDS IDs through the user contact inter-
face (https://www.ncbi.nlm.nih.gov/CCDS/UserRequest/
UserRequest.cgi). Internally, these cases either involve
a discussion and voting process described in an earlier
report (4) or have a ‘Public Note’ on the CCDS report
page explaining an update that was made to the CCDS
record. This level of review results in the CCDS ID be-
ing designated as ‘Reviewed (by CCDS collaboration)’
(example CCDS48347.1). CCDS IDs that meet both
above-mentioned levels of review get the ‘Reviewed (by
RefSeq, HAVANA and CCDS collaboration)’ label (ex-
ample CCDS16957.2). Conversely, CCDS IDs that do
not meet any of these levels of review are assigned the
‘Provisional’ review status (example CCDS45069.1).
Figure 5 shows the distribution of human and mouse
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Figure 5. Distribution of human and mouse CCDS IDs by their ‘Review
status’ in the current human (Release 20) and mouse (Release 21) CCDS
releases at the time of data freeze. Details of the review status categories
and sub-categories are provided in Table 1. Reviewed 1 = CCDS IDs re-
viewed ‘by RefSeq and HAVANA’, Reviewed 2 = CCDS IDs reviewed ‘by
CCDS collaboration’, Reviewed 3=CCDS IDs reviewed ‘by RefSeq, HA-
VANA and CCDS collaboration’.
CCDS IDs among these review categories. Review status is
available only for the CCDS IDs of the current release. At
the time of the data freeze for the CCDS release, the current
human CCDS set (Release 20) had 30 181 (out of a 32 524
total) ‘Reviewed’ CCDS IDs, while the current mouse set
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Table 1. Description of CCDS ‘Review Status’ categories
Review status category Public description of category Detailed description
Provisional ‘this record has not been manually reviewed
by the collaboration’
The CCDS ID does not have a ‘validated’ or ‘reviewed’ RefSeq or a
VEGA accession associated with it; nor was it reviewed by the CCDS
collaboration
Reviewed • ‘by RefSeq and HAVANA’ • The CCDS ID is associated with at least one ‘validated’ or ‘reviewed’
RefSeq AND at least one VEGA accession, which are manually reviewed
by curators at NCBI and Ensembl-HAVANA groups, respectively.
• ‘by CCDS collaboration’ • The CCDS ID was reviewed by curators in the CCDS collaboration.
• ‘by RefSeq, HAVANA and CCDS
collaboration’
• The CCDS ID meets both ‘by RefSeq and HAVANA’ and ‘by CCDS
collaboration’ review requirements.
(Release 21) had 16 740 (out of a 25 757 total) ‘Reviewed’
CCDS IDs.
Expert curation
The CCDS collaboration continues to provide expert cu-
ration support to the human and mouse datasets. Since
our last publication, the CCDS collaboration reviewed sev-
eral genes which led to improved annotation that is more
consistent with the supporting data. For example, a new
gene,ASDURF (ASNSD1 upstream reading frame) was de-
fined based on transcript data and conservation of the 96
amino-acid protein, which was included earlier as a prod-
uct of the ASNSD1 gene (Human CCDS2300.1; Mouse
CCDS14954.1, CCDS69888.1). The CCDS collaboration
reviews genes that are currently annotated as non-coding
genes, but where recent evidence indicates they may en-
code small proteins. For example, the human gene SMIM27
(NCBI GeneID:100129250, ENSG00000235453, formerly
TOPORS-AS1) and its mouse ortholog Smim27 (NCBI
GeneID:100504309, ENSMUSG00000028407) are now an-
notated as protein-coding genes, based on orthology, ribo-
some profiling elongation and PhyloCSF (16) data.
On several occasions, the CCDS collaboration has
worked with scientific research groups to improve annota-
tion of genes. A notable example of the benefit of cooper-
ative expert curation is reflected in the updated annotation
of human MIA2 and CTAGE5 and their mouse orthologs,
following a discussion of these genes by the CCDS collab-
oration, prompted by a review request from the UniProt
group. These genome features were annotated as indepen-
dent genes by NCBI (Annotation Release 108) and En-
sembl (Release 85). CCDS collaborators merged the two
genes into a single gene, MIA2, based on published data
on the human (17) and mouse (18) genes, direct consul-
tations with the research groups and new data submit-
ted to INSDC (KX388743.1, representing the TANGO1-
like transcript, TALI, which contains both MIA2-specific
and CTAGE5-specific exons). The CTAGE5 protein was re-
tained as a splice variant ofMIA2 and a new transcript vari-
ant (RefSeq transcript NM 001329214.2; Ensembl tran-
script ENST00000640607.1), based on TALI, was created.
Similar changes were made in the representation of the
mouse Mia2 gene as well. Following these changes, the
nomenclature groups agreed to merge their records and
retain the symbol MIA2 and Mia2, for the human and
mouse genes, respectively. Such annotation changes made
by CCDS curators are reflected in the subsequent updates
of the NCBI and Ensembl genome annotations. The CCDS
dataset reflects the change in the new CCDS build, which,
as mentioned earlier, is typically released after NCBI and
Ensembl produce updated versions of their gene sets.
In addition to the manual review of specific genes or
CCDS IDs, the collaboration regularly reviews targeted lists
with a common goal. For example, curators recently re-
viewed a list of around 250 genes that are annotated by both
Ensembl and NCBI, but have different gene biotypes (typ-
ically protein-coding versus pseudogene versus long non-
coding RNA). As a result of this review, both annotation
groups agreed on consistent gene biotypes for about 70
genes. Where disagreements remain, a common factor is
the lack of sufficient transcriptomic or proteomic evidence
to confirm or confidently suggest a biotype. These cases
will be subject to iterative review as additional data be-
come available. A second task involved the review of genes
(86 human and 130 mouse genes) that were represented in
the CCDS database, but had differing gene symbols in the
NCBI and Ensembl databases. This review led to the cor-
rection of gene symbols in both annotation sets based on
standard names provided by the respective nomenclature
authorities. Last year, the CCDS collaborators undertook
a review of human-mouse orthologs to ensure that both or-
thologs were represented in the CCDS dataset when sup-
porting data were available. Such targeted curation on a
regular basis ensures the accuracy and consistency of the
CCDS dataset.
Sometimes, accurate annotation of coding regions is lim-
ited by factors that are beyond the control of annotation
pipelines and expert curators. Despite several rounds of im-
provement, human and mouse reference genome assembly
errors continue to pose a challenge for accurate CCDS an-
notations. CCDS curators continue to report genome prob-
lems to the GRC (Genome Reference Consortium) (19),
who provide curation support to improve the reference
genome assemblies of select organisms, including human
and mouse. The resolution of genome assembly errors in a
new assembly version results in the addition of new CCDS
IDs due to improved gene representations in the NCBI and
Ensembl annotations. For example, CCDS75980.1 (human
geneDGKK) was gained following consensus annotation on
the GRCh38 (20) assembly after a single nucleotide dele-
tion which existed in the GRCh37 assembly was fixed. In
total, about 150 human CCDS IDs were gained based on
the GRCh38 assembly following the resolution of genome
assembly problems that existed in the GRCh37 assembly.
Data types used in manual curation
New, improved or more highly robust data types that sup-
port gene, transcript or protein existence continue to emerge
through biological research. Expert curators in the CCDS
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Table 2. Data types used in CCDS manual curation decisions
Data type Curation decisions
RNA-seq (24) Determination of transcript or gene structure or extent, inferred exon combination, splice variant existence
CAGE tags (25) Determination of transcription start sites, 5′ UTR extension
H3K4me3 methylation Determination of general 5′ completeness of transcripts or genes
CpG islands Determination of general 5′ completeness of transcripts or genes (in conjunction with other data)
Long read transcriptome data Splice variants; especially useful for genes with poor INSDC transcript support
Proteomics Determination of gene biotype, novel exons, novel protein termini.
Ribosome profiling Determination of translation start codons or the coding status of genes with questionable biotypes
Conservation in other species Determination of gene biotype, annotation of proteins with little or no data about gene function, determination
of translation start codon
Conserved protein domains Determination of gene biotype, annotation of proteins with little or no data about gene function
PhyloCSF Determination of gene biotype, annotation of uncharacterized proteins
polyA-seq (26) Determination of 3′ completeness
collaboration adapt to such data types and incorporate
them in curation/annotation workflows to provide accurate
coding region annotations. Table 2 lists themore recent data
types that have been adopted by CCDS curators to make
key decisions. Most of the listed data types are used in man-
ual review and are not yet incorporated in the automated
annotation pipelines (except short-read and long-read tran-
scriptome data). Typically, these data types are considered
for genes that lack traditional support such as mRNAs and
ESTs which are archived by INSDC databases, or they may
lack information about gene function. Hence, such genes
are reviewed on a case-by-case basis with additional sup-
port gleaned from newer data types where appropriate.
CONTRIBUTIONS FROM RESEARCH COMMUNITIES
Almost all the annotation included in the CCDS dataset is
evidence-based and is supported by experimental data, in-
cluding transcript, protein and other data types (Table 2)
submitted by the research community to public databases
such as INSDC. The curation examples cited in this paper
underline the importance of sequence data submitted by re-
search groups to public archives, as well as data published
in peer-reviewed journals, for improving gene annotation. A
small percentage of protein-coding genes remain excluded
from the CCDS dataset owing to the lack of sequence data
and lack of any information that would indicate the func-
tion of the gene. New data may lead to the consensus anno-
tation of these genes in the NCBI and Ensembl annotation
sets, and thus, their inclusion in the CCDS dataset. There-
fore, it is important that research groups submit sequence
data generated by them to public archives. Further, studies
in hitherto uncharacterized genes will serve as a crucial re-
source and help CCDS curators improve their annotation.
The CCDS collaboration also welcomes direct input from
the research community for the annotation of specific genes
and gene families. Such input can be communicated via the
user contact email link, as mentioned above.
FUTURE DIRECTIONS
Although dataset analyses indicate the addition of new an-
notation and stability in the existing consensus annotation
of protein-coding regions in the Ensembl and NCBI anno-
tations (Figure 1), a small percentage of genes still lack con-
sistent annotation. These may be cases where one group has
annotated a coding gene and the other has not; the latter
may have annotated a gene with a different gene type––i.e.
non-coding or pseudogene––or may not have described any
gene at all. Such cases are naturally a top priority for review
by the CCDS curators. In particular, the interpretation of
genes predicted to encode small proteins or small open read-
ing frames (smORFs) and non-coding RNAs pose chal-
lenges for gene annotation (21,22), and thereby pose chal-
lenges for the completion of the CCDS dataset. Interpre-
tation of new datasets including ribosome profiling, cross-
species conservation, evolutionary conservation of synony-
mous codons in ORFs and mass spectrometry promises
to help resolve some of the uncertainty about these genes.
Nonetheless, gene-level biotype differences may persist be-
tween the Ensembl and NCBI annotation sets even after
some of these genes have been debated. Such cases ulti-
mately reflect differences between the annotation guidelines
of these projects, specifically on how to judge the balance of
probability when the evidence for annotation is limited or
ambiguous.
While the CCDS project assists navigation between the
Ensembl and NCBI databases, users may be confused by
inconsistent terminology used by different annotation and
nomenclature groups to describe gene and transcript bio-
types. To provide consistent terms and further enhance nav-
igation across different genome annotation resources, all
members of the CCDS collaborative group have, or plan to,
implement Sequence Ontology (23) terms to label genome
feature biotypes.
Data pertaining to the ‘Review status’ (Figure 5) indicate
that there are still a significant number of mouse CCDS IDs
and a smaller number of human CCDS IDs that lack a ‘Re-
viewed’ status. It is our aim to review all provisional CCDS
IDswith a goal of eventually providing completely reviewed
human and mouse CCDS datasets.
Although the primary focus of the CCDS collaboration
is the representation of protein-coding regions, it is also a
platform for members of major bioinformatics resources
to discuss new ideas, share strategies about using emerging
data types for genome annotation and predict user needs
based on the latest research trends. For example, user in-
terest has spurred recent discussions in topics such as rec-
onciling the UTRs of transcripts across independent anno-
tation sets and assigning one representative transcript per
gene. Further discussions and analyses are needed to ex-
plore providing potential deliverables based on these ideas.
The CCDS collaboration continues in its pursuit to provide
agreement in the annotation of human and mouse protein-
coding genes in reference gene sets while constantly adapt-
ing to emerging data types and user needs. With the help of
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new data in public archives and input from research groups,
we will continue working toward the long-term goal of pro-
viding consistent and stable annotation of protein-coding
genes on the human and mouse reference genome assem-
blies.
ACKNOWLEDGEMENTS
The authors wish to thank all programmers and other
staff at NCBI, EMBL-EBI, UCSC, HGNC andMGI, who
contributed to CCDS analyses and maintenance of the
CCDS database and its internal curation interface. The au-
thors also thankUniProtKB curators, scientific experts and
CCDS users for their helpful inputs.
FUNDING
Work performed at NCBI is supported by the Intra-
mural Research Program of the National Institutes of
Health, National Library of Medicine. Work related to
Ensembl annotation is supported by the Wellcome Trust
[WT098051, WT108749/Z/15/Z], the National Human
Genome Research Institute (NHGRI) [U41HG007234,
2U41HG007234] and the European Molecular Biology
Laboratory. Work performed at HGNC is supported by an
NHGRI grant [U41HG003345] and aWellcomeTrust grant
[099129/Z/12/Z]. Work performed at the MGI group is
supported in part by an NHGRI grant [U41HG000330].
Work performed at UCSC is supported by the NHGRI
grant for the GENCODE project [U41HG007234].
Conflict of interest statement.None declared.
REFERENCES
1. O’Leary,N.A., Wright,M.W., Brister,J.R., Ciufo,S., Haddad,D.,
McVeigh,R., Rajput,B., Robbertse,B., Smith-White,B., Ako-Adjei,D.
et al. (2016) Reference sequence (RefSeq) database at NCBI: current
status, taxonomic expansion, and functional annotation. Nucleic
Acids Res., 44, D733–D745.
2. Aken,B.L., Ayling,S., Barrell,D., Clarke,L., Curwen,V., Fairley,S.,
Fernandez Banet,J., Billis,K., Garcia Giron,C., Hourlier,T. et al.
(2016) The Ensembl gene annotation system. Database, 2016, 1–19.
3. Pruitt,K.D., Harrow,J., Harte,R.A., Wallin,C., Diekhans,M.,
Maglott,D.R., Searle,S., Farrell,C.M., Loveland,J.E., Ruef,B.J. et al.
(2009) The consensus coding sequence (CCDS) project: Identifying a
common protein-coding gene set for the human and mouse genomes.
Genome Res., 19, 1316–1323.
4. Harte,R.A., Farrell,C.M., Loveland,J.E., Suner,M.M., Wilming,L.,
Aken,B., Barrell,D., Frankish,A., Wallin,C., Searle,S. et al. (2012)
Tracking and coordinating an international curation effort for the
CCDS Project. Database, 2012, bas008.
5. Farrell,C.M., O’Leary,N.A., Harte,R.A., Loveland,J.E.,
Wilming,L.G., Wallin,C., Diekhans,M., Barrell,D., Searle,S.M.,
Aken,B. et al. (2014) Current status and new features of the
Consensus Coding Sequence database. Nucleic Acids Res., 42,
D865–D872.
6. Harrow,J., Frankish,A., Gonzalez,J.M., Tapanari,E., Diekhans,M.,
Kokocinski,F., Aken,B.L., Barrell,D., Zadissa,A., Searle,S. et al.
(2012) GENCODE: the reference human genome annotation for The
ENCODE Project. Genome Res., 22, 1760–1774.
7. Yates,B., Braschi,B., Gray,K.A., Seal,R.L., Tweedie,S. and
Bruford,E.A. (2017) Genenames.org: the HGNC and VGNC
resources in 2017. Nucleic Acids Res., 45, D619–D625.
8. Eppig,J.T., Smith,C.L., Blake,J.A., Ringwald,M., Kadin,J.A.,
Richardson,J.E. and Bult,C.J. (2017) Mouse Genome Informatics
(MGI): resources for mining mouse genetic, genomic, and biological
data in support of primary and translational research.Methods Mol.
Biol., 1488, 47–73.
9. Belkadi,A., Bolze,A., Itan,Y., Cobat,A., Vincent,Q.B., Antipenko,A.,
Shang,L., Boisson,B., Casanova,J.L. and Abel,L. (2015)
Whole-genome sequencing is more powerful than whole-exome
sequencing for detecting exome variants. Proc. Natl. Acad. Sci.
U.S.A., 112, 5473–5478.
10. Ezkurdia,I., Rodriguez,J.M., Carrillo-de Santa Pau,E., Vazquez,J.,
Valencia,A. and Tress,M.L. (2015) Most highly expressed
protein-coding genes have a single dominant isoform. J. Proteome
Res., 14, 1880–1887.
11. Manase,D., D’Alessandro,L.C., Manickaraj,A.K., Al Turki,S.,
Hurles,M.E. and Mital,S. (2014) High throughput exome coverage of
clinically relevant cardiac genes. BMCMed. Genomics, 7, 67.
12. Chen,R., Im,H. and Snyder,M. (2015) Whole-exome enrichment with
the Agilent SureSelect human all exon platform. Cold Spring Harb.
Protoc., 2015, 626–633.
13. Cochrane,G., Karsch-Mizrachi,I., Takagi,T. and International
Nucleotide Sequence Database, C. (2016) The International
Nucleotide Sequence Database Collaboration. Nucleic Acids Res., 44,
D48–D50.
14. Pundir,S., Martin,M.J. and O’Donovan,C. (2017) UniProt Protein
Knowledgebase.Methods Mol. Biol., 1558, 41–55.
15. Harrow,J.L., Steward,C.A., Frankish,A., Gilbert,J.G., Gonzalez,J.M.,
Loveland,J.E., Mudge,J., Sheppard,D., Thomas,M., Trevanion,S.
et al. (2014) The Vertebrate Genome Annotation browser 10 years on.
Nucleic Acids Res., 42, D771–D779.
16. Lin,M.F., Jungreis,I. and Kellis,M. (2011) PhyloCSF: a comparative
genomics method to distinguish protein coding and non-coding
regions. Bioinformatics, 27, i275–i282.
17. Santos,A.J., Nogueira,C., Ortega-Bellido,M. and Malhotra,V. (2016)
TANGO1 and Mia2/cTAGE5 (TALI) cooperate to export bulky
pre-chylomicrons/VLDLs from the endoplasmic reticulum. J. Cell
Biol., 213, 343–354.
18. Pitman,J.L., Bonnet,D.J., Curtiss,L.K. and Gekakis,N. (2011)
Reduced cholesterol and triglycerides in mice with a mutation in
Mia2, a liver protein that localizes to ER exit sites. J. Lipid Res., 52,
1775–1786.
19. Church,D.M., Schneider,V.A., Graves,T., Auger,K., Cunningham,F.,
Bouk,N., Chen,H.C., Agarwala,R., McLaren,W.M., Ritchie,G.R.
et al. (2011) Modernizing reference genome assemblies. PLoS Biol., 9,
e1001091.
20. Schneider,V.A., Graves-Lindsay,T., Howe,K., Bouk,N., Chen,H.C.,
Kitts,P.A., Murphy,T.D., Pruitt,K.D., Thibaud-Nissen,F.,
Albracht,D. et al. (2017) Evaluation of GRCh38 and de novo haploid
genome assemblies demonstrates the enduring quality of the reference
assembly. Genome Res., 27, 849–864.
21. Pauli,A., Valen,E. and Schier,A.F. (2015) Identifying (non-)coding
RNAs and small peptides: challenges and opportunities. Bioessays,
37, 103–112.
22. Makarewich,C.A. and Olson,E.N. (2017) Mining for Micropeptides.
Trends Cell Biol., 27, 685–696.
23. Eilbeck,K., Lewis,S.E., Mungall,C.J., Yandell,M., Stein,L.,
Durbin,R. and Ashburner,M. (2005) The Sequence Ontology: a tool
for the unification of genome annotations. Genome Biol., 6, R44.
24. Mortazavi,A., Williams,B.A., McCue,K., Schaeffer,L. and Wold,B.
(2008) Mapping and quantifying mammalian transcriptomes by
RNA-Seq. Nat. Methods, 5, 621–628.
25. Shiraki,T., Kondo,S., Katayama,S., Waki,K., Kasukawa,T.,
Kawaji,H., Kodzius,R., Watahiki,A., Nakamura,M., Arakawa,T.
et al. (2003) Cap analysis gene expression for high-throughput
analysis of transcriptional starting point and identification of
promoter usage. Proc. Natl. Acad. Sci. U.S.A., 100, 15776–15781.
26. Derti,A., Garrett-Engele,P., Macisaac,K.D., Stevens,R.C., Sriram,S.,
Chen,R., Rohl,C.A., Johnson,J.M. and Babak,T. (2012) A
quantitative atlas of polyadenylation in five mammals. Genome Res.
22, 1173–1183.
Downloaded from https://academic.oup.com/nar/article-abstract/46/D1/D221/4595661
by Jackson Laboratory user
on 21 February 2018
